Your Article Summary
See Latest ArticlesTumor Biomarkers in Melanoma
Cancer Control, 06/30/09
Ugurel S et al. - The process of biomarker identification and validation is providing a rapidly changing molecularview of melanoma, a strategy that is necessary for developing truly stratified or even personalized preventionor management.
Related Articles
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 97%
Slow-growing melanoma: a dermoscopy follow-up study
British Journal of Dermatology, 10/05/09
Relevance Score: 93%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 91%
ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09
Relevance Score: 91%
KIT as a Therapeutic Target in Melanoma
Journal of Investigative Dermatology, 10/23/09
Relevance Score: 90%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ipilimumab monotherapy in patients with pretreated advanced melanoma: A randomised, double-blind, multicentre, phase 2, dose-ranging study
The Lancet Oncology - Online First, 12/08/09
GLI1 genotypes do not predict basal cell carcinoma risk: a case control study
Molecular Cancer, 12/08/09
Multimodality management for 145 cases of Merkel cell carcinoma
Medical Oncology, 12/08/09